CO4230094A1 - Composiciones - Google Patents
ComposicionesInfo
- Publication number
- CO4230094A1 CO4230094A1 CO94021615A CO94021615A CO4230094A1 CO 4230094 A1 CO4230094 A1 CO 4230094A1 CO 94021615 A CO94021615 A CO 94021615A CO 94021615 A CO94021615 A CO 94021615A CO 4230094 A1 CO4230094 A1 CO 4230094A1
- Authority
- CO
- Colombia
- Prior art keywords
- methyl
- excipients
- pharmaceutically acceptable
- carbazol
- ona
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Abstract
REIVINDICACION NUMERO UNA COMPOSICION FARMACEUTICA, PARA ADMINISTRACION RECTAL, CARACTERIZADA PORQUE COMPREDNE 1,2,3,9-TE- TRAHIDRO-9-METIL-3- ((2-METIL-1H-IMIDAZOL-1-IL)- METIL)4H-CARBAZOL-4-ONA, EN FORMA DE SU PASE LIBRE O DE UN SOLVATO FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, COMO INGREDIENTE ACTIVO, JUNTO CON UNO O MAS PORTADORES O EXCIPIENTES FARMACEUTICAMENTE A- CEPTABLES". REIVINDICACION NUMERO UN METODO PARA EL TRATAMIENTO DE UN MAMIFERO, IN- CLUYENDO EL HOMBRE, QUE SUFRE O ES SUSCEPTIBLE DE UNA CONDICION MEDIADA A TRAVES DE LA ACCION DE LA 5-HIDROXITRIPTAMINA, EN LOS RECEPTORES 5-HT3, EL CUAL METODO COMPRENDE LA ADMINISTRACION RECTAL DE UNA COMPOSICION FARMACEUTICA QUE COMPRENDE LA 1,2,3,9-TETRAHIDRO-9-METIL-3-2((2-METIL-1H-IMIDA- ZOL-1-IL)-METIL)-4H-CARBAZOL-4-ONA, EN FORMA DE SU BASE LIBRE O DE UN SOLVATO FARMACEUTICAMENTE ACEP- TABLE DE LA MISMA, COMO INGREDIENTE ACTIVO, JUNTO CON UNO O MAS PORTADORES O EXCIPIENTES FARMACEUTI- CAMENTE ACEPTABLES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4230094A1 true CO4230094A1 (es) | 1995-10-19 |
Family
ID=10736089
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO94021615A CO4230094A1 (es) | 1993-05-25 | 1994-05-23 | Composiciones |
Country Status (38)
Country | Link |
---|---|
US (1) | US5741806A (es) |
EP (1) | EP0700290B1 (es) |
JP (1) | JP2965703B2 (es) |
KR (1) | KR100297212B1 (es) |
CN (1) | CN1106194C (es) |
AP (1) | AP544A (es) |
AT (1) | ATE183643T1 (es) |
AU (1) | AU680918B2 (es) |
BE (1) | BE1007158A3 (es) |
BR (1) | BR1100046A (es) |
CA (1) | CA2162919C (es) |
CO (1) | CO4230094A1 (es) |
CY (1) | CY2411B1 (es) |
CZ (1) | CZ291041B6 (es) |
DE (1) | DE69420266T2 (es) |
DK (1) | DK0700290T3 (es) |
EC (1) | ECSP941088A (es) |
ES (1) | ES2136198T3 (es) |
FR (1) | FR2705569B1 (es) |
GB (2) | GB9310756D0 (es) |
GR (1) | GR3031669T3 (es) |
HR (2) | HRP940315B1 (es) |
HU (1) | HU227121B1 (es) |
IE (1) | IE80632B1 (es) |
IL (1) | IL109749A (es) |
IS (1) | IS1868B (es) |
IT (1) | IT1272990B (es) |
MY (1) | MY111445A (es) |
NO (1) | NO306448B1 (es) |
NZ (1) | NZ267415A (es) |
PE (1) | PE13395A1 (es) |
PL (1) | PL175578B1 (es) |
RU (1) | RU2132684C1 (es) |
SA (1) | SA94150003B1 (es) |
SG (1) | SG48119A1 (es) |
SI (1) | SI0700290T1 (es) |
WO (1) | WO1994027599A1 (es) |
ZA (1) | ZA943593B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ535135A (en) * | 1998-06-15 | 2006-04-28 | Sepracor Inc | Use of optically pure (+)-norcisapride for treating bulimia and other disorders |
AU764474B2 (en) * | 1998-06-15 | 2003-08-21 | Sepracor, Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
AU7931301A (en) * | 2000-08-04 | 2002-02-18 | Dmi Biosciences Inc | Method of using diketopiperazines and composition containing them |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
CH664152A5 (fr) * | 1984-01-25 | 1988-02-15 | Glaxo Group Ltd | Derives de tetrahydrocarbazolones. |
GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active IP Right Cessation
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en active IP Right Grant
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002355A1 (es) | Composiciones y metodos para administracion local de agentes farmaceuticamente activos. | |
CO5680428A2 (es) | Antagonistas del receptor de trombina | |
CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
ES2145774T3 (es) | Derivados de adenosina que tienen actividad agonista en a2. | |
BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
ES2150663T3 (es) | Tratamiento de la incontinencia urinaria utilizando (s)-oxibutinina y (s)-desetiloxibutinina. | |
ES2174129T3 (es) | Antagonistas de la hormona de liberacion de la gonadotropina. | |
PA8468401A1 (es) | Compuestos para el tratamiento de la isquemia | |
NL300385I1 (nl) | Synergistic combinations comprising a renin inhibitor for cardiovascular diseases. | |
RS54390B1 (sr) | Kombinovana vakcina protiv mycoplasma hyopneumoniae i svinjskog cirkovirusa | |
PA8496301A1 (es) | Inhibidores de metaloproteasas. | |
CY1105931T1 (el) | Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας | |
GT199700095A (es) | Derivados 6,5-heterobiciclicos sustituidos. | |
ES2088388T3 (es) | Composiciones de macrolido para el tratamiento de trastornos de movilidad gastrointestinal. | |
CO5261519A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
ES2156287T3 (es) | Derivados de difenilmetilen piperidina. | |
AR024998A1 (es) | Nuevos retinoides para el tratamiento del enfisema | |
UY27208A1 (es) | Una combinación que comprende combretastatina y agentes anticarcinógenos. | |
CO4230094A1 (es) | Composiciones | |
ES2171911T3 (es) | Poliaminas conformacionalmente restringidas y su uso como agentes antineoplasicos. | |
AR005970A1 (es) | Compuestos de benzotiofeno y formulaciones farmaceuticas que los contienen como agente activo | |
TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
ES2113533T3 (es) | Composiciones farmaceuticas de alquilsulfonamidas agonistas de 5-ht1 para administracion rectal. | |
AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion |